-
Figure 1 KHI's first decade by the numbers
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
2.
American Society of Nephrology. Celeste Castillo Lee In Memoriam. https://www.asn-online.org/about/memoriam.aspx?ID=23
-
3.
KidneyX Innovation Accelerator. Prize competitions: Patient Innovator Challenge. https://www.kidneyx.org/prize-competitions/patient-innovator-challenge/
-
4.
Levey AS, et al. Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2020; 97:1117–1129. doi: 10.1016/j.kint.2020.02.010
-
5.
Falk RJ. ASN Presidential Address 2012: Time to cure kidney disease. J Am Soc Nephrol 2013; 24:1040–1043. doi: 10.1681/ASN.2013050440
-
6.
Palmer SC, et al. Trial quality in nephrology: How are we measuring up? Am J Kidney Dis 2011; 58:335–337. doi: 10.1053/j.ajkd.2011.06.006
-
7.
U.S. Food & Drug Administration. Accelerated Approval Program. May 30, 2023. https://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program\
-
8.
Levey AS, et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: A scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis 2020; 75:84–104. doi: 10.1053/j.ajkd.2019.06.009
-
9.
Inker LA, et al.; NKF-FDA Conference on Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases Advisory Group. Clinical trial considerations in developing treatments for early stages of common chronic kidney diseases: A scientific workshop cosponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2022; 80:513–526. doi: 10.1053/j.ajkd.2022.03.011
-
10.
Moe SM. Written testimony – House Space, Science and Technology Committee. 2014. https://www.asn-online.org/policy/webdocs/sharonmmoewrittentestimonyasn.pdf
-
11.
Meyer R. ASN, KHI announce new initiatives at White House Organ Summit. Kidney News, July 2016; 8(7):1–2. https://www.kidneynews.org/view/journals/kidney-news/8/7/article-p1_2.xml
-
12.
Kidney Health Initiative. Technology roadmap for innovative approaches to renal replacement therapy. https://khi.asn-online.org/rrtroadmap
-
13.
National Archives. Advancing American Kidney Health. Federal Register, Executive Order 13879 of July 10, 2019. https://www.federalregister.gov/documents/2019/07/15/2019-15159/advancing-american-kidney-health
-
14.
KidneyX Innovation Accelerator. Prize competitions: Artificial Kidney Prize Phase 2. https://www.kidneyx.org/prize-competitions/artificial-kidney-prize-phase-2/
-
15.
Novartis. Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40/share). June 12, 2023. https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-medicines-strategy-and-renal-pipeline-agreement-acquire-chinook-therapeutics-usd-32bn-upfront-usd-40-share
ASN Executive Vice President's Update: The Kidney Health Initiative Has Surpassed Every Expectation
Tod Ibrahim
Tod Ibrahim
Tod Ibrahim, MLA, is Executive Vice President, American Society of Nephrology, Washington, DC. You can reach him at tibrahim@asn-online.org.
Search for other papers by Tod Ibrahim in
Current site
Google Scholar
PubMed
Search for other papers by Tod Ibrahim in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory